PDB Short entry for 4MG8 HEADER HORMONE RECEPTOR 28-AUG-13 4MG8 TITLE CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH ALPHA-ZEARALANOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN (UNP RESIDUES 302-552); COMPND 5 SYNONYM: ER, ER-ALPHA, ESTRADIOL RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY COMPND 6 3 GROUP A MEMBER 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ESTROGEN RECEPTOR; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: LIGAND BINDING DOMAIN (UNP RESIDUES 302-552); COMPND 13 SYNONYM: ER, ER-ALPHA, ESTRADIOL RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY COMPND 14 3 GROUP A MEMBER 1; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 19 CHAIN: C, D; COMPND 20 FRAGMENT: COACTIVATOR PEPTIDE SRC-1 (UNP RESIDUES 686-698); COMPND 21 SYNONYM: NCOA-1, CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 74, BHLHE74, COMPND 22 PROTEIN HIN-2, RIP160, RENAL CARCINOMA ANTIGEN NY-REN-52, STEROID COMPND 23 RECEPTOR COACTIVATOR 1, SRC-1; COMPND 24 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR, ESR1, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET32A; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: ESR, ESR1, NR3A1; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET32A; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606 KEYWDS LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR V.DELFOSSE,M.GRIMALDI,W.BOURGUET REVDAT 5 06-DEC-23 4MG8 1 REMARK REVDAT 4 20-SEP-23 4MG8 1 REMARK SEQADV LINK REVDAT 3 17-DEC-14 4MG8 1 JRNL REVDAT 2 08-OCT-14 4MG8 1 JRNL REVDAT 1 03-SEP-14 4MG8 0 JRNL AUTH V.DELFOSSE,M.GRIMALDI,V.CAVAILLES,P.BALAGUER,W.BOURGUET JRNL TITL STRUCTURAL AND FUNCTIONAL PROFILING OF ENVIRONMENTAL LIGANDS JRNL TITL 2 FOR ESTROGEN RECEPTORS. JRNL REF ENVIRON.HEALTH PERSPECT. V. 122 1306 2014 JRNL REFN ISSN 0091-6765 JRNL PMID 25260197 JRNL DOI 10.1289/EHP.1408453 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.05 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 41649 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2084 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.0695 - 4.5615 0.99 2704 143 0.1749 0.1771 REMARK 3 2 4.5615 - 3.6210 0.98 2646 139 0.1503 0.1821 REMARK 3 3 3.6210 - 3.1634 0.99 2658 140 0.1679 0.1821 REMARK 3 4 3.1634 - 2.8742 0.98 2633 139 0.1797 0.2084 REMARK 3 5 2.8742 - 2.6682 0.99 2609 137 0.1891 0.2330 REMARK 3 6 2.6682 - 2.5109 0.99 2670 141 0.1890 0.2498 REMARK 3 7 2.5109 - 2.3852 0.99 2629 138 0.1829 0.2584 REMARK 3 8 2.3852 - 2.2814 0.99 2635 139 0.1762 0.2253 REMARK 3 9 2.2814 - 2.1935 0.99 2624 138 0.1739 0.2397 REMARK 3 10 2.1935 - 2.1178 0.99 2647 139 0.1794 0.2398 REMARK 3 11 2.1178 - 2.0516 0.99 2608 138 0.1900 0.2209 REMARK 3 12 2.0516 - 1.9930 0.99 2675 141 0.2041 0.2770 REMARK 3 13 1.9930 - 1.9405 0.99 2605 137 0.2370 0.2815 REMARK 3 14 1.9405 - 1.8932 0.99 2623 138 0.2551 0.3147 REMARK 3 15 1.8932 - 1.8500 0.97 2599 137 0.2755 0.3188 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.37 REMARK 3 B_SOL : 62.57 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.99490 REMARK 3 B22 (A**2) : -2.75690 REMARK 3 B33 (A**2) : -10.23800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 6.92210 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4138 REMARK 3 ANGLE : 0.967 5613 REMARK 3 CHIRALITY : 0.064 659 REMARK 3 PLANARITY : 0.003 700 REMARK 3 DIHEDRAL : 17.667 1551 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE PRESENCE IN THE ASYMMETRIC UNIT OF REMARK 3 TWO ESTROGEN RECEPTOR MOLECULES WITH DISTINCT PATTERNS OF SIDE REMARK 3 CHAIN MODIFICATION REPRESENTS THE BEST FIT TO THE ELECTRON REMARK 3 DENSITY AND IS NOT DERIVED FROM THE CO-CRYSTALLIZATION OF TWO REMARK 3 CHEMICALLY DISTINCT PROTEINS. REMARK 4 REMARK 4 4MG8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1000081871. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-OCT-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97934 REMARK 200 MONOCHROMATOR : LIQUID NITROGEN COOLED CHANNEL REMARK 200 -CUT SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41670 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 47.054 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.0100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.41400 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.530 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: PDB ENTRY 3UUD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 300 MM SODIUM CHLORIDE, 100 MM HEPES, REMARK 280 24% PEG3350, PH 7.75, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.91500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20140 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 298 REMARK 465 SER A 299 REMARK 465 HIS A 300 REMARK 465 MET A 301 REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 GLY B 298 REMARK 465 SER B 299 REMARK 465 HIS B 300 REMARK 465 MET B 301 REMARK 465 LYS B 302 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 LEU B 469 REMARK 465 GLU B 470 REMARK 465 GLU B 471 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 ARG C 686 REMARK 465 GLY C 697 REMARK 465 SER C 698 REMARK 465 ARG D 686 REMARK 465 GLY D 697 REMARK 465 SER D 698 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 306 CG CD1 CD2 REMARK 470 LYS A 401 CD CE NZ REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 LEU A 466 CG CD1 CD2 REMARK 470 LYS A 467 CG CD CE NZ REMARK 470 SER A 468 OG REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 GLU A 471 CG CD OE1 OE2 REMARK 470 LYS A 472 CG CD CE NZ REMARK 470 LYS A 481 CD CE NZ REMARK 470 LYS A 492 CD CE NZ REMARK 470 LYS A 529 NZ REMARK 470 LYS A 531 CG CD CE NZ REMARK 470 ASN A 532 CG OD1 ND2 REMARK 470 VAL A 533 CG1 CG2 REMARK 470 VAL A 534 CG1 CG2 REMARK 470 ARG A 548 CD NE CZ NH1 NH2 REMARK 470 LYS B 303 CG CD CE NZ REMARK 470 LEU B 306 CD1 CD2 REMARK 470 GLU B 330 CG CD OE1 OE2 REMARK 470 THR B 334 OG1 CG2 REMARK 470 LYS B 472 CG CD CE NZ REMARK 470 ARG B 477 NE CZ NH1 NH2 REMARK 470 LYS B 520 CE NZ REMARK 470 LYS B 529 CE NZ REMARK 470 LYS B 531 CG CD CE NZ REMARK 470 VAL B 533 CG1 CG2 REMARK 470 ARG B 548 NE CZ NH1 NH2 REMARK 470 HIS C 687 CG ND1 CD2 CE1 NE2 REMARK 470 HIS D 687 CG ND1 CD2 CE1 NE2 REMARK 470 GLU D 696 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG B 548 59.03 37.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 27J A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 27J B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 603 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3UU7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BISPHENOL-A REMARK 900 RELATED ID: 3UUA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BISPHENOL-AF REMARK 900 RELATED ID: 3UUC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HERA-LBD (WT) IN COMPLEX WITH BISPHENOL-C REMARK 900 RELATED ID: 3UUD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH ESTRADIOL REMARK 900 RELATED ID: 4MG5 RELATED DB: PDB REMARK 900 RELATED ID: 4MG6 RELATED DB: PDB REMARK 900 RELATED ID: 4MG7 RELATED DB: PDB REMARK 900 RELATED ID: 4MG9 RELATED DB: PDB REMARK 900 RELATED ID: 4MGA RELATED DB: PDB REMARK 900 RELATED ID: 4MGB RELATED DB: PDB REMARK 900 RELATED ID: 4MGC RELATED DB: PDB REMARK 900 RELATED ID: 4MGD RELATED DB: PDB DBREF 4MG8 A 302 552 UNP P03372 ESR1_HUMAN 302 552 DBREF 4MG8 B 302 552 UNP P03372 ESR1_HUMAN 302 552 DBREF 4MG8 C 686 698 UNP Q15788 NCOA1_HUMAN 686 698 DBREF 4MG8 D 686 698 UNP Q15788 NCOA1_HUMAN 686 698 SEQADV 4MG8 GLY A 298 UNP P03372 EXPRESSION TAG SEQADV 4MG8 SER A 299 UNP P03372 EXPRESSION TAG SEQADV 4MG8 HIS A 300 UNP P03372 EXPRESSION TAG SEQADV 4MG8 MET A 301 UNP P03372 EXPRESSION TAG SEQADV 4MG8 SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 4MG8 GLY B 298 UNP P03372 EXPRESSION TAG SEQADV 4MG8 SER B 299 UNP P03372 EXPRESSION TAG SEQADV 4MG8 HIS B 300 UNP P03372 EXPRESSION TAG SEQADV 4MG8 MET B 301 UNP P03372 EXPRESSION TAG SEQADV 4MG8 SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 255 GLY SER HIS MET LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 A 255 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 A 255 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 A 255 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 A 255 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 A 255 ARG VAL PRO GLY PHE VAL ASP LEU THR LEU HIS ASP GLN SEQRES 7 A 255 VAL HIS LEU LEU GLU CSO ALA TRP LEU GLU ILE LEU MET SEQRES 8 A 255 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 A 255 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 A 255 GLY LYS CSO VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 A 255 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 A 255 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 A 255 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 A 255 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 A 255 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 A 255 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 A 255 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 A 255 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CYS LYS SEQRES 19 A 255 ASN VAL VAL PRO LEU SER ASP LEU LEU LEU GLU MET LEU SEQRES 20 A 255 ASP ALA HIS ARG LEU HIS ALA PRO SEQRES 1 B 255 GLY SER HIS MET LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 B 255 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 B 255 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 B 255 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 B 255 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 B 255 ARG VAL PRO GLY PHE VAL ASP LEU THR LEU HIS ASP GLN SEQRES 7 B 255 VAL HIS LEU LEU GLU CSO ALA TRP LEU GLU ILE LEU MET SEQRES 8 B 255 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 B 255 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 B 255 GLY LYS CSO VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 B 255 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 B 255 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 B 255 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 B 255 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 B 255 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 B 255 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 B 255 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 B 255 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CSO LYS SEQRES 19 B 255 ASN VAL VAL PRO LEU SER ASP LEU LEU LEU GLU MET LEU SEQRES 20 B 255 ASP ALA HIS ARG LEU HIS ALA PRO SEQRES 1 C 13 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER SEQRES 1 D 13 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER MODRES 4MG8 CSO A 381 CYS S-HYDROXYCYSTEINE MODRES 4MG8 CSO A 417 CYS S-HYDROXYCYSTEINE MODRES 4MG8 CSO B 381 CYS S-HYDROXYCYSTEINE MODRES 4MG8 CSO B 417 CYS S-HYDROXYCYSTEINE MODRES 4MG8 CSO B 530 CYS S-HYDROXYCYSTEINE HET CSO A 381 11 HET CSO A 417 7 HET CSO B 381 11 HET CSO B 417 7 HET CSO B 530 7 HET 27J A 601 23 HET GOL A 602 6 HET EDO A 603 4 HET 27J B 601 23 HET EDO B 602 4 HET EDO B 603 4 HETNAM CSO S-HYDROXYCYSTEINE HETNAM 27J ALPHA-ZEARALANOL HETNAM GOL GLYCEROL HETNAM EDO 1,2-ETHANEDIOL HETSYN 27J (3S,7R)-7,14,16-TRIHYDROXY-3-METHYL-3,4,5,6,7,8,9,10, HETSYN 2 27J 11,12-DECAHYDRO-1H-2-BENZOXACYCLOTETRADECIN-1-ONE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 CSO 5(C3 H7 N O3 S) FORMUL 5 27J 2(C18 H26 O5) FORMUL 6 GOL C3 H8 O3 FORMUL 7 EDO 3(C2 H6 O2) FORMUL 11 HOH *243(H2 O) HELIX 1 1 LEU A 306 LEU A 310 5 5 HELIX 2 2 THR A 311 GLU A 323 1 13 HELIX 3 3 SER A 338 LYS A 362 1 25 HELIX 4 4 GLY A 366 LEU A 370 5 5 HELIX 5 5 THR A 371 MET A 396 1 26 HELIX 6 6 ASP A 411 LYS A 416 1 6 HELIX 7 7 MET A 421 ASN A 439 1 19 HELIX 8 8 GLN A 441 SER A 456 1 16 HELIX 9 9 LYS A 467 ALA A 493 1 27 HELIX 10 10 THR A 496 ASN A 532 1 37 HELIX 11 11 SER A 537 HIS A 547 1 11 HELIX 12 12 SER B 305 LEU B 310 5 6 HELIX 13 13 THR B 311 GLU B 323 1 13 HELIX 14 14 SER B 338 LYS B 362 1 25 HELIX 15 15 THR B 371 SER B 395 1 25 HELIX 16 16 ARG B 412 LYS B 416 1 5 HELIX 17 17 MET B 421 MET B 438 1 18 HELIX 18 18 GLN B 441 SER B 456 1 16 HELIX 19 19 GLY B 457 PHE B 461 5 5 HELIX 20 20 ASP B 473 ALA B 493 1 21 HELIX 21 21 THR B 496 ASN B 532 1 37 HELIX 22 22 SER B 537 ALA B 546 1 10 HELIX 23 23 LYS C 688 GLU C 696 1 9 HELIX 24 24 LYS D 688 GLU D 696 1 9 SHEET 1 A 2 LEU A 402 ALA A 405 0 SHEET 2 A 2 LEU A 408 LEU A 410 -1 O LEU A 410 N LEU A 402 SHEET 1 B 2 LYS B 401 ALA B 405 0 SHEET 2 B 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 LINK C GLU A 380 N CSO A 381 1555 1555 1.32 LINK C CSO A 381 N ALA A 382 1555 1555 1.33 LINK C LYS A 416 N CSO A 417 1555 1555 1.33 LINK C CSO A 417 N VAL A 418 1555 1555 1.33 LINK C GLU B 380 N CSO B 381 1555 1555 1.33 LINK C CSO B 381 N ALA B 382 1555 1555 1.34 LINK C LYS B 416 N CSO B 417 1555 1555 1.33 LINK C CSO B 417 N VAL B 418 1555 1555 1.33 LINK C LYS B 529 N CSO B 530 1555 1555 1.33 LINK C CSO B 530 N LYS B 531 1555 1555 1.33 CISPEP 1 ARG B 335 PRO B 336 0 0.16 SITE 1 AC1 11 LEU A 346 LEU A 349 ALA A 350 GLU A 353 SITE 2 AC1 11 LEU A 387 MET A 388 LEU A 391 LEU A 428 SITE 3 AC1 11 GLY A 521 HIS A 524 LEU A 525 SITE 1 AC2 3 LEU A 320 GLU A 323 TRP A 393 SITE 1 AC3 4 ASN A 439 GLN A 441 ARG A 503 HOH A 783 SITE 1 AC4 12 LEU B 346 LEU B 349 ALA B 350 GLU B 353 SITE 2 AC4 12 LEU B 387 MET B 388 LEU B 391 MET B 421 SITE 3 AC4 12 LEU B 428 GLY B 521 HIS B 524 LEU B 525 SITE 1 AC5 2 GLU B 323 TRP B 393 SITE 1 AC6 4 ASN B 439 GLN B 441 ALA B 493 HOH B 804 CRYST1 55.950 81.830 58.570 90.00 110.70 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017873 0.000000 0.006754 0.00000 SCALE2 0.000000 0.012220 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018252 0.00000